High-Risk Patient Profiles Using for Off-Label Weight Loss (No Diabetes) The July 2024 study found 7x higher NAION risk in patients taking semaglutide for weight loss versus diabetes
FDA-Approved Medications For anyone researching SkinnyRx, this is the most important distinction to understand upfront
Research Applications In the realm of scientific research, BPC-157 has been primarily explored for its potential applications in wound healing, muscle and tendon repair, and cognitive health
Susan Spratt, an endocrinologist and the senior medical director for the Population Health Management Office at Duke Health in North Carolina, questioned whether the increased risk was due to the rapid weight loss or some other mechanism of the drug
Keep careful notes: record dose, time, lot number, and any symptoms
If you purchase JHUP books, like The Lupus Encyclopedia, you support projects like Project MUSE